Published in Rev Med Chil on January 01, 2004
Gallbladder cancer: expert consensus statement. HPB (Oxford) (2015) 1.10
miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer. Int J Clin Exp Pathol (2014) 0.98
Chemotherapy and targeted therapy for gall bladder cancer. Indian J Surg Oncol (2014) 0.77
Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet (2011) 1.47
[Concordance between Gleason scores of trans rectal biopsies and the surgical piece of radical prostatectomy]. Rev Med Chil (2011) 1.42
Vulnerable carina anatomy and ostial lesions in the left anterior descending coronary artery after floating-stent treatment. Rev Esp Cardiol (2009) 1.39
Gallbladder cancer: a morphological and molecular update. Histopathology (2009) 1.31
[Prevalence of human papillomavirus genital infection among male university students]. Rev Med Chil (2008) 1.31
Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J (2004) 1.25
Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol (2012) 1.23
Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol (2012) 1.17
Criteria for pathologic sampling of gallbladder specimens. Am J Clin Pathol (2013) 1.13
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma. Cancer Biol Ther (2010) 1.12
The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance. Virchows Arch (2014) 1.10
Liver abscess of hydatid origin: clinical features and results of aggressive treatment. ANZ J Surg (2003) 1.05
Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J (2004) 1.02
Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. J Gastrointest Surg (2006) 0.99
Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth. Mol Cell Biol (2012) 0.95
Description of Echinococcus granulosus genotypes in human hydatidosis in a region of southern Chile. Parasitol Int (2008) 0.95
Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas. Arch Pathol Lab Med (2012) 0.94
Prognostic factors of phyllodes tumor of the breast. Pathol Int (2006) 0.92
[Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer]. Rev Med Chil (2006) 0.89
Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma. Cancer Biol Ther (2015) 0.88
Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. J Gastroenterol (2005) 0.87
DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clin Epigenetics (2012) 0.87
Chemoradiotherapy in gallbladder cancer. J Surg Oncol (2006) 0.87
SILAC-based quantitative proteomic analysis of gastric cancer secretome. Proteomics Clin Appl (2013) 0.87
[Promoter methylation profile in gastric cancer]. Rev Med Chil (2005) 0.86
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg (2015) 0.84
Surgery for morbid obesity: selection of operation based on evidence from literature review. Obes Surg (2005) 0.84
Promoter methylation profile in gallbladder cancer. J Gastroenterol (2006) 0.84
Early gallbladder cancer: is further treatment necessary? J Surg Oncol (2009) 0.82
Quantitative phosphoproteomic analysis of IL-33-mediated signaling. Proteomics (2015) 0.81
[Is impact factor an appropriate index to determine the level of evidence of studies on therapeutic procedures in surgery journals?]. Cir Esp (2005) 0.81
[Human papilloma virus (HPV) typing in preneoplastic and neoplastic lesions of the uterine cervix in the IX region-Chile]. Rev Med Chil (2003) 0.80
Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer. Clin Proteomics (2012) 0.80
Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions. Mol Carcinog (2009) 0.80
[Promoter methylation profile in breast cancer]. Rev Med Chil (2004) 0.79
HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivo. Blood (2012) 0.79
[K-ras gene mutation in gallbladder carcinoma]. Rev Med Chil (2004) 0.79
The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer. Int J Cancer (2013) 0.79
[Microsatellite instability and loss of heterozygosity in neoplastic and preneoplastic gastric lesions]. Rev Med Chil (2003) 0.78
Survival of a cohort of patients with intermediate and advanced gall bladder cancer treated with a prospective therapeutic protocol. Acta Cir Bras (2010) 0.78
Cellular FLICE-like inhibitory protein long form (c-FLIPL) overexpression is related to cervical cancer progression. Int J Gynecol Pathol (2013) 0.77
[Inflammation and plaque instability]. Arch Cardiol Mex (2008) 0.77
HFE gene mutations in Chile. Ann Intern Med (2003) 0.77
[Association between Helicobacter pylori genotype and the severity of gastritis in infected adults]. Rev Med Chil (2004) 0.77
Clinical and public health research using methylated DNA immunoprecipitation (MeDIP): a comparison of commercially available kits to examine differential DNA methylation across the genome. Epigenetics (2012) 0.77
[KRAS gene mutation in colorectal cancer]. Rev Med Chil (2013) 0.77
[Genetic alterations in preneoplastic and neoplastic injuries of the gallbladder]. Rev Med Chil (2010) 0.77
[Reversion of hypophosphatemia after the excision of a composite hemangioendothelioma in the great toe]. Rev Med Chil (2003) 0.77
Ultrasound study of the prevalence of plaque at the carina in lesions that affect the coronary bifurcation. Implications for treatment with provisional stent. Rev Esp Cardiol (2010) 0.77
[Morphological prognostic elements in gallbladder cancer]. Rev Med Chil (2002) 0.77
[Detection of human papilloma virus in cytologic samples or biopsies of the cervix]. Rev Med Chil (2005) 0.76
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases. World J Surg Oncol (2013) 0.76
[Duodenal villous atrophy associated with Mycophenolate mofetil: report of one case]. Rev Med Chil (2010) 0.76
S1PR4 is required for plasmacytoid dendritic cell differentiation. Biol Chem (2015) 0.76
[Inactivation of CDKN2A gene (p16) in gallbladder carcinoma]. Rev Med Chil (2004) 0.76
Teneurin protein family: an emerging role in human tumorigenesis and drug resistance. Cancer Lett (2012) 0.76
[Genetic changes in chronic gastritis: study of microsatellite instability and loss of heterozygosity]. Rev Med Chil (2003) 0.76
Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas. Am J Surg Pathol (2011) 0.76
[Is gallbladder cancer a disease with bad prognosis?]. Rev Med Chil (2002) 0.76
IL-1 family cytokines in cancer immunity - a matter of life and death. Biol Chem (2016) 0.75
Uncommon locations of abdominal hydatid disease. Trop Doct (2003) 0.75
[Genetic methylation in carcinogenesis and its application in clinical oncology]. Med Clin (Barc) (2006) 0.75
What is the methodologic quality of human therapy studies in ISI surgical publications? Ann Surg (2006) 0.75
[BRAF gene mutation in wild-type KRAS patients with colorectal cancers]. Rev Med Chil (2014) 0.75
Synchronous ileocecal and duodenal tuberculosis: case report and review of the literature. Int J Colorectal Dis (2014) 0.75
[Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology]. Med Clin (Barc) (2008) 0.75
[Quality of DNA from archival pathological samples of gallbladder cancer]. Rev Med Chil (2013) 0.75
[HER2 gene amplification and overexpression in advanced gastric cancer]. Rev Med Chil (2013) 0.75
Treatment of the residual cavity during hepatic hydatidosis surgery: a cohort study of capitonnage vs. omentoplasty. Surg Today (2013) 0.75
[Frequency of abdominal aortic aneurysms in adult population with known risk factors]. Rev Med Chil (2003) 0.75
General characteristics of treatable, reversible, and untreatable dementias. Am J Geriatr Cardiol (2007) 0.75
[Management of gallbladder cancer with invasion of the muscular layer]. Rev Med Chil (2004) 0.75
[Endoscopic submucosal dissection in early gastric cancer: Experience in 16 patients]. Rev Med Chil (2015) 0.75
[Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach]. Rev Med Chil (2003) 0.75
[Detection of bone marrow micrometastases in patients with gallbladder cancer]. Rev Med Chil (2004) 0.75
[Cystic tumors of the pancreas]. Rev Med Chil (2008) 0.75
Abdominal echinococcosis during pregnancy: clinical aspects and management of a series of cases in Chile. Trop Doct (2004) 0.75
[Detection of BCR-ABL gene sequences using RT-PCR in patients with leukemia in the IX region. Chile]. Rev Med Chil (2002) 0.75
[Frequency of K-ras mutation in biliary and pancreatic tumors]. Rev Med Chil (2006) 0.75
[Primary hyperthyroidism after excision of a Struma ovarii]. Rev Med Chil (2003) 0.75
[Hepatocarcinoma with sarcomatoid transformation: case report]. Rev Med Chil (2007) 0.75
[Methodological quality of an article on the treatment of gastric cancer adopted as protocol by some Chilean hospitals]. Rev Med Chil (2006) 0.75
[Prognostic factors for gastric cancer without lymph node involvement]. Rev Med Chil (2011) 0.75